As Recommendations for Isolation End, How Common is Long COVID?
This issue brief analyzes the latest data on rates of long COVID, which have appeared to stabilize, affecting about 1 in 10 adults who have had COVID.
View the Latest: Public Health
Filter
-
-
“Healthification”: The Good and Bad of Making Everything a Health Issue
From Drew AltmanIn his new column, KFF President and CEO Drew Altman discusses the pros and cons of labeling socio-economic problems as health issues.
-
Who is at Risk Amid the H5N1 Influenza Outbreak? Characteristics and Health Coverage of Animal Production Workers
Issue BriefThis analysis uses data on “animal production workers” from the 2022 American Community Survey to examine characteristics of workers who may be at risk for exposure to H5N1 avian influenza, which has been found in dairy cattle herds in nine U.S. states as of May 14, 2024. The analysis compares characteristics of these workers to all U.S. workers, to all workers in the H5N1-affected states, and draws out some implications. Among the findings are that animal production workers are more likely than workers overall to be Hispanic and noncitizen immigrants, as well as to be uninsured.
-
How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?
Issue BriefThis analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.
-
New Federal Support for the Public Health Workforce: Analysis of Funding by Jurisdiction
Issue BriefThis issue brief analyzes how the new CDC Public Health Infrastructure Grant (PHIG) workforce funding has been distributed across health departments in the U.S., and also jurisdictional plans for public health workforce hiring using funds from PHIG.
-
Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States
Issue BriefThis analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.
-
Analysis: There is Significant Variation in State and Local Eligibility Criteria for Monkeypox Vaccines, and Vaccine Information is not Always Accessible
News ReleaseAccording to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk.
-
National Data Show Continuing Disparities in Monkeypox (MPX) Cases and Vaccinations Among Black and Hispanic People
Issue BriefThis analysis examines monkeypox (MPX) cases and vaccinations by race/ethnicity based on national data obtained from the Centers for Disease Control and Prevention (CDC). We find that while the current MPX outbreak in U.S. appears to be slowing down, disparities persist among Black and Hispanic people.
-
Half of the Public Would Likely Get an Annual COVID-19 Vaccine Offered Like a Flu Shot
News ReleaseMore than three years into the COVID-19 pandemic, about half (53%) the public says they would likely get an annual COVID-19 vaccine if offered similar to an annual flu shot, the latest KFF COVID-19 Vaccine Monitor finds. This includes about a third (32%) who would be “very likely” to do so.
-
Eight to 24 Million Could Lose Medicaid Coverage by May 2024 Due to the End of Pandemic-era Enrollment Protections
News ReleaseA new KFF analysis finds that between 8 and 24 million people across the U.S. could be disenrolled from Medicaid during the unwinding of the program’s continuous enrollment provision. The estimates draw on data collected through KFF’s recent survey of state Medicaid and CHIP officials, conducted with the Georgetown University Center for Children and Families.